nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—CCBL1—kidney cancer	0.364	0.514	CbGaD
L-Glutamine—PPAT—kidney cancer	0.178	0.251	CbGaD
L-Glutamine—TGM2—kidney cancer	0.167	0.236	CbGaD
L-Glutamine—Aminolevulinic acid—ALAD—kidney cancer	0.00215	0.557	CrCbGaD
L-Glutamine—NADSYN1—nephron tubule—kidney cancer	0.00185	0.0264	CbGeAlD
L-Glutamine—TGM1—cardiac atrium—kidney cancer	0.00176	0.0251	CbGeAlD
L-Glutamine—GATB—nephron tubule—kidney cancer	0.0017	0.0242	CbGeAlD
L-Glutamine—CCBL1—renal system—kidney cancer	0.00154	0.022	CbGeAlD
L-Glutamine—GATB—renal system—kidney cancer	0.00154	0.022	CbGeAlD
L-Glutamine—GATB—kidney—kidney cancer	0.00149	0.0213	CbGeAlD
L-Glutamine—CCBL1—kidney—kidney cancer	0.00149	0.0213	CbGeAlD
L-Glutamine—PFAS—nephron tubule—kidney cancer	0.00146	0.0209	CbGeAlD
L-Glutamine—GLS—renal system—kidney cancer	0.00146	0.0207	CbGeAlD
L-Glutamine—GATB—cortex of kidney—kidney cancer	0.00145	0.0207	CbGeAlD
L-Glutamine—CCBL1—cortex of kidney—kidney cancer	0.00145	0.0207	CbGeAlD
L-Glutamine—TGM2—renal system—kidney cancer	0.00144	0.0205	CbGeAlD
L-Glutamine—GLS—kidney—kidney cancer	0.00141	0.02	CbGeAlD
L-Glutamine—TGM2—kidney—kidney cancer	0.00139	0.0198	CbGeAlD
L-Glutamine—GATB—cardiac atrium—kidney cancer	0.00138	0.0197	CbGeAlD
L-Glutamine—GLS—cortex of kidney—kidney cancer	0.00137	0.0195	CbGeAlD
L-Glutamine—CTPS1—renal system—kidney cancer	0.00136	0.0193	CbGeAlD
L-Glutamine—GMPS—renal system—kidney cancer	0.00136	0.0193	CbGeAlD
L-Glutamine—GFPT2—renal system—kidney cancer	0.00133	0.019	CbGeAlD
L-Glutamine—F13A1—nephron tubule—kidney cancer	0.00131	0.0187	CbGeAlD
L-Glutamine—GLS—gonad—kidney cancer	0.0013	0.0186	CbGeAlD
L-Glutamine—TGM2—gonad—kidney cancer	0.00129	0.0184	CbGeAlD
L-Glutamine—GFPT2—kidney—kidney cancer	0.00129	0.0183	CbGeAlD
L-Glutamine—PFAS—cortex of kidney—kidney cancer	0.00125	0.0178	CbGeAlD
L-Glutamine—QARS—nephron tubule—kidney cancer	0.00125	0.0178	CbGeAlD
L-Glutamine—CTPS1—gonad—kidney cancer	0.00122	0.0173	CbGeAlD
L-Glutamine—GMPS—gonad—kidney cancer	0.00122	0.0173	CbGeAlD
L-Glutamine—F13A1—renal system—kidney cancer	0.00119	0.017	CbGeAlD
L-Glutamine—PFAS—gonad—kidney cancer	0.00119	0.017	CbGeAlD
L-Glutamine—GFPT2—gonad—kidney cancer	0.00119	0.017	CbGeAlD
L-Glutamine—PFAS—cardiac atrium—kidney cancer	0.00119	0.017	CbGeAlD
L-Glutamine—GFPT2—cardiac atrium—kidney cancer	0.00119	0.017	CbGeAlD
L-Glutamine—F13A1—kidney—kidney cancer	0.00115	0.0164	CbGeAlD
L-Glutamine—QARS—renal system—kidney cancer	0.00114	0.0162	CbGeAlD
L-Glutamine—F13A1—cortex of kidney—kidney cancer	0.00112	0.016	CbGeAlD
L-Glutamine—QARS—kidney—kidney cancer	0.0011	0.0156	CbGeAlD
L-Glutamine—F13A1—gonad—kidney cancer	0.00107	0.0153	CbGeAlD
L-Glutamine—F13A1—cardiac atrium—kidney cancer	0.00107	0.0152	CbGeAlD
L-Glutamine—QARS—cortex of kidney—kidney cancer	0.00107	0.0152	CbGeAlD
L-Glutamine—QARS—gonad—kidney cancer	0.00102	0.0145	CbGeAlD
L-Glutamine—QARS—cardiac atrium—kidney cancer	0.00102	0.0145	CbGeAlD
L-Glutamine—SLC1A5—nephron tubule—kidney cancer	0.000989	0.0141	CbGeAlD
L-Glutamine—L-Aspartic Acid—ACY1—kidney cancer	0.000987	0.256	CrCbGaD
L-Glutamine—CAD—gonad—kidney cancer	0.000939	0.0134	CbGeAlD
L-Glutamine—SLC1A5—renal system—kidney cancer	0.000899	0.0128	CbGeAlD
L-Glutamine—SLC7A8—nephron tubule—kidney cancer	0.00089	0.0127	CbGeAlD
L-Glutamine—PPAT—gonad—kidney cancer	0.000871	0.0124	CbGeAlD
L-Glutamine—SLC1A5—kidney—kidney cancer	0.000869	0.0124	CbGeAlD
L-Glutamine—SLC1A5—cortex of kidney—kidney cancer	0.000846	0.0121	CbGeAlD
L-Glutamine—SLC7A8—renal system—kidney cancer	0.000809	0.0115	CbGeAlD
L-Glutamine—SLC1A5—cardiac atrium—kidney cancer	0.000805	0.0115	CbGeAlD
L-Glutamine—SLC7A8—kidney—kidney cancer	0.000783	0.0111	CbGeAlD
L-Glutamine—SLC7A8—cortex of kidney—kidney cancer	0.000762	0.0109	CbGeAlD
L-Glutamine—ASNS—cortex of kidney—kidney cancer	0.000726	0.0103	CbGeAlD
L-Glutamine—SLC7A8—gonad—kidney cancer	0.000726	0.0103	CbGeAlD
L-Glutamine—GLUL—nephron tubule—kidney cancer	0.000693	0.00987	CbGeAlD
L-Glutamine—ASNS—cardiac atrium—kidney cancer	0.000691	0.00984	CbGeAlD
L-Glutamine—GLUL—renal system—kidney cancer	0.00063	0.00897	CbGeAlD
L-Glutamine—GLUL—kidney—kidney cancer	0.000609	0.00867	CbGeAlD
L-Glutamine—GLUL—cortex of kidney—kidney cancer	0.000593	0.00845	CbGeAlD
L-Glutamine—GLUL—gonad—kidney cancer	0.000565	0.00805	CbGeAlD
L-Glutamine—PFAS—Everolimus—Temsirolimus—kidney cancer	0.000554	0.163	CbGdCrCtD
L-Glutamine—CTPS1—Sirolimus—Everolimus—kidney cancer	0.000538	0.158	CbGdCrCtD
L-Glutamine—CTPS1—Sirolimus—Temsirolimus—kidney cancer	0.000538	0.158	CbGdCrCtD
L-Glutamine—SLC16A10—nephron tubule—kidney cancer	0.000528	0.00753	CbGeAlD
L-Glutamine—PPAT—Sirolimus—Everolimus—kidney cancer	0.000486	0.143	CbGdCrCtD
L-Glutamine—PPAT—Temsirolimus—Everolimus—kidney cancer	0.000486	0.143	CbGdCrCtD
L-Glutamine—PPAT—Sirolimus—Temsirolimus—kidney cancer	0.000486	0.143	CbGdCrCtD
L-Glutamine—SLC16A10—cortex of kidney—kidney cancer	0.000452	0.00644	CbGeAlD
L-Glutamine—SLC16A10—gonad—kidney cancer	0.000431	0.00614	CbGeAlD
L-Glutamine—QARS—Azacitidine—Gemcitabine—kidney cancer	0.000315	0.0926	CbGdCrCtD
L-Glutamine—Glutathione—GSTT1—kidney cancer	0.000273	0.0708	CrCbGaD
L-Glutamine—Glutathione—GSTM1—kidney cancer	0.000233	0.0605	CrCbGaD
L-Glutamine—Glutathione—GSTP1—kidney cancer	0.000216	0.0559	CrCbGaD
L-Glutamine—Vomiting—Pazopanib—kidney cancer	0.000152	0.00139	CcSEcCtD
L-Glutamine—Rash—Pazopanib—kidney cancer	0.00015	0.00138	CcSEcCtD
L-Glutamine—Nausea—Temsirolimus—kidney cancer	0.00015	0.00138	CcSEcCtD
L-Glutamine—Dermatitis—Pazopanib—kidney cancer	0.00015	0.00137	CcSEcCtD
L-Glutamine—Back pain—Gemcitabine—kidney cancer	0.00015	0.00137	CcSEcCtD
L-Glutamine—Candida infection—Doxorubicin—kidney cancer	0.00015	0.00137	CcSEcCtD
L-Glutamine—Abdominal pain—Vinblastine—kidney cancer	0.000149	0.00137	CcSEcCtD
L-Glutamine—Headache—Pazopanib—kidney cancer	0.000149	0.00137	CcSEcCtD
L-Glutamine—Rhinitis—Paclitaxel—kidney cancer	0.000149	0.00136	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000149	0.00136	CcSEcCtD
L-Glutamine—Oedema—Dactinomycin—kidney cancer	0.000149	0.00136	CcSEcCtD
L-Glutamine—Body temperature increased—Everolimus—kidney cancer	0.000149	0.00136	CcSEcCtD
L-Glutamine—Abdominal pain—Everolimus—kidney cancer	0.000149	0.00136	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Erlotinib—kidney cancer	0.000149	0.00136	CcSEcCtD
L-Glutamine—Sweating increased—Capecitabine—kidney cancer	0.000149	0.00136	CcSEcCtD
L-Glutamine—Infection—Dactinomycin—kidney cancer	0.000148	0.00135	CcSEcCtD
L-Glutamine—Pharyngitis—Paclitaxel—kidney cancer	0.000148	0.00135	CcSEcCtD
L-Glutamine—Urinary tract disorder—Paclitaxel—kidney cancer	0.000147	0.00134	CcSEcCtD
L-Glutamine—Urethral disorder—Paclitaxel—kidney cancer	0.000146	0.00133	CcSEcCtD
L-Glutamine—Body temperature increased—Erlotinib—kidney cancer	0.000144	0.00131	CcSEcCtD
L-Glutamine—Abdominal pain—Erlotinib—kidney cancer	0.000144	0.00131	CcSEcCtD
L-Glutamine—Ill-defined disorder—Gemcitabine—kidney cancer	0.000143	0.00131	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000143	0.00131	CcSEcCtD
L-Glutamine—Insomnia—Sunitinib—kidney cancer	0.000142	0.0013	CcSEcCtD
L-Glutamine—Nausea—Pazopanib—kidney cancer	0.000142	0.0013	CcSEcCtD
L-Glutamine—Fatigue—Sorafenib—kidney cancer	0.000141	0.00129	CcSEcCtD
L-Glutamine—Pain—Sorafenib—kidney cancer	0.00014	0.00128	CcSEcCtD
L-Glutamine—Constipation—Sorafenib—kidney cancer	0.00014	0.00128	CcSEcCtD
L-Glutamine—Malaise—Gemcitabine—kidney cancer	0.000139	0.00128	CcSEcCtD
L-Glutamine—Hypersensitivity—Vinblastine—kidney cancer	0.000139	0.00127	CcSEcCtD
L-Glutamine—Myalgia—Vincristine—kidney cancer	0.000139	0.00127	CcSEcCtD
L-Glutamine—Hypersensitivity—Everolimus—kidney cancer	0.000139	0.00127	CcSEcCtD
L-Glutamine—Sepsis—Doxorubicin—kidney cancer	0.000136	0.00124	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000136	0.00124	CcSEcCtD
L-Glutamine—Asthenia—Vinblastine—kidney cancer	0.000136	0.00124	CcSEcCtD
L-Glutamine—Fatigue—Sunitinib—kidney cancer	0.000136	0.00124	CcSEcCtD
L-Glutamine—Depression—Capecitabine—kidney cancer	0.000136	0.00124	CcSEcCtD
L-Glutamine—Asthenia—Everolimus—kidney cancer	0.000135	0.00124	CcSEcCtD
L-Glutamine—Angiopathy—Paclitaxel—kidney cancer	0.000135	0.00123	CcSEcCtD
L-Glutamine—Pain—Sunitinib—kidney cancer	0.000135	0.00123	CcSEcCtD
L-Glutamine—Constipation—Sunitinib—kidney cancer	0.000135	0.00123	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000134	0.00122	CcSEcCtD
L-Glutamine—Chills—Paclitaxel—kidney cancer	0.000133	0.00122	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Capecitabine—kidney cancer	0.000133	0.00122	CcSEcCtD
L-Glutamine—Pruritus—Everolimus—kidney cancer	0.000133	0.00122	CcSEcCtD
L-Glutamine—Oedema—Vincristine—kidney cancer	0.000133	0.00122	CcSEcCtD
L-Glutamine—Infection—Vincristine—kidney cancer	0.000132	0.00121	CcSEcCtD
L-Glutamine—Chest pain—Gemcitabine—kidney cancer	0.000132	0.0012	CcSEcCtD
L-Glutamine—Myalgia—Gemcitabine—kidney cancer	0.000132	0.0012	CcSEcCtD
L-Glutamine—Arthralgia—Gemcitabine—kidney cancer	0.000132	0.0012	CcSEcCtD
L-Glutamine—Asthenia—Erlotinib—kidney cancer	0.00013	0.00119	CcSEcCtD
L-Glutamine—Mental disorder—Paclitaxel—kidney cancer	0.00013	0.00119	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Doxorubicin—kidney cancer	0.00013	0.00119	CcSEcCtD
L-Glutamine—Discomfort—Gemcitabine—kidney cancer	0.00013	0.00119	CcSEcCtD
L-Glutamine—Malnutrition—Paclitaxel—kidney cancer	0.000129	0.00118	CcSEcCtD
L-Glutamine—Body temperature increased—Sorafenib—kidney cancer	0.000129	0.00118	CcSEcCtD
L-Glutamine—Abdominal pain—Sorafenib—kidney cancer	0.000129	0.00118	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000129	0.00118	CcSEcCtD
L-Glutamine—Hyperhidrosis—Vincristine—kidney cancer	0.000129	0.00118	CcSEcCtD
L-Glutamine—Pruritus—Erlotinib—kidney cancer	0.000129	0.00118	CcSEcCtD
L-Glutamine—Fatigue—Dactinomycin—kidney cancer	0.000128	0.00117	CcSEcCtD
L-Glutamine—Flatulence—Paclitaxel—kidney cancer	0.000128	0.00117	CcSEcCtD
L-Glutamine—Pain—Dactinomycin—kidney cancer	0.000127	0.00116	CcSEcCtD
L-Glutamine—Oedema—Gemcitabine—kidney cancer	0.000126	0.00115	CcSEcCtD
L-Glutamine—Infection—Gemcitabine—kidney cancer	0.000125	0.00115	CcSEcCtD
L-Glutamine—Back pain—Paclitaxel—kidney cancer	0.000125	0.00115	CcSEcCtD
L-Glutamine—Dizziness—Vinblastine—kidney cancer	0.000125	0.00114	CcSEcCtD
L-Glutamine—Dizziness—Everolimus—kidney cancer	0.000125	0.00114	CcSEcCtD
L-Glutamine—Body temperature increased—Sunitinib—kidney cancer	0.000124	0.00114	CcSEcCtD
L-Glutamine—Abdominal pain—Sunitinib—kidney cancer	0.000124	0.00114	CcSEcCtD
L-Glutamine—Feeling abnormal—Dactinomycin—kidney cancer	0.000123	0.00112	CcSEcCtD
L-Glutamine—Rhinitis—Capecitabine—kidney cancer	0.000122	0.00112	CcSEcCtD
L-Glutamine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000122	0.00112	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000122	0.00111	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000121	0.00111	CcSEcCtD
L-Glutamine—Pharyngitis—Capecitabine—kidney cancer	0.000121	0.00111	CcSEcCtD
L-Glutamine—Urinary tract disorder—Capecitabine—kidney cancer	0.000121	0.0011	CcSEcCtD
L-Glutamine—Hypersensitivity—Sorafenib—kidney cancer	0.00012	0.0011	CcSEcCtD
L-Glutamine—Insomnia—Vincristine—kidney cancer	0.00012	0.0011	CcSEcCtD
L-Glutamine—Vomiting—Vinblastine—kidney cancer	0.00012	0.0011	CcSEcCtD
L-Glutamine—Dizziness—Erlotinib—kidney cancer	0.00012	0.0011	CcSEcCtD
L-Glutamine—Ill-defined disorder—Paclitaxel—kidney cancer	0.00012	0.0011	CcSEcCtD
L-Glutamine—Vomiting—Everolimus—kidney cancer	0.00012	0.0011	CcSEcCtD
L-Glutamine—Urethral disorder—Capecitabine—kidney cancer	0.00012	0.00109	CcSEcCtD
L-Glutamine—Rash—Everolimus—kidney cancer	0.000119	0.00109	CcSEcCtD
L-Glutamine—Dermatitis—Everolimus—kidney cancer	0.000119	0.00108	CcSEcCtD
L-Glutamine—Headache—Vinblastine—kidney cancer	0.000118	0.00108	CcSEcCtD
L-Glutamine—Headache—Everolimus—kidney cancer	0.000118	0.00108	CcSEcCtD
L-Glutamine—Abdominal pain—Dactinomycin—kidney cancer	0.000118	0.00108	CcSEcCtD
L-Glutamine—Body temperature increased—Dactinomycin—kidney cancer	0.000118	0.00108	CcSEcCtD
L-Glutamine—Asthenia—Sorafenib—kidney cancer	0.000117	0.00107	CcSEcCtD
L-Glutamine—Malaise—Paclitaxel—kidney cancer	0.000117	0.00107	CcSEcCtD
L-Glutamine—Hypersensitivity—Sunitinib—kidney cancer	0.000116	0.00106	CcSEcCtD
L-Glutamine—Pruritus—Sorafenib—kidney cancer	0.000116	0.00106	CcSEcCtD
L-Glutamine—Vomiting—Erlotinib—kidney cancer	0.000116	0.00106	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000115	0.00105	CcSEcCtD
L-Glutamine—Fatigue—Vincristine—kidney cancer	0.000115	0.00105	CcSEcCtD
L-Glutamine—Rash—Erlotinib—kidney cancer	0.000115	0.00105	CcSEcCtD
L-Glutamine—Dermatitis—Erlotinib—kidney cancer	0.000114	0.00105	CcSEcCtD
L-Glutamine—Insomnia—Gemcitabine—kidney cancer	0.000114	0.00104	CcSEcCtD
L-Glutamine—Headache—Erlotinib—kidney cancer	0.000114	0.00104	CcSEcCtD
L-Glutamine—Constipation—Vincristine—kidney cancer	0.000114	0.00104	CcSEcCtD
L-Glutamine—Pain—Vincristine—kidney cancer	0.000114	0.00104	CcSEcCtD
L-Glutamine—Asthenia—Sunitinib—kidney cancer	0.000113	0.00103	CcSEcCtD
L-Glutamine—Nausea—Vinblastine—kidney cancer	0.000112	0.00103	CcSEcCtD
L-Glutamine—Nausea—Everolimus—kidney cancer	0.000112	0.00102	CcSEcCtD
L-Glutamine—Pruritus—Sunitinib—kidney cancer	0.000111	0.00102	CcSEcCtD
L-Glutamine—Angiopathy—Capecitabine—kidney cancer	0.000111	0.00101	CcSEcCtD
L-Glutamine—Myalgia—Paclitaxel—kidney cancer	0.00011	0.00101	CcSEcCtD
L-Glutamine—Chest pain—Paclitaxel—kidney cancer	0.00011	0.00101	CcSEcCtD
L-Glutamine—Arthralgia—Paclitaxel—kidney cancer	0.00011	0.00101	CcSEcCtD
L-Glutamine—Hypersensitivity—Dactinomycin—kidney cancer	0.00011	0.001	CcSEcCtD
L-Glutamine—Chills—Capecitabine—kidney cancer	0.00011	0.001	CcSEcCtD
L-Glutamine—Discomfort—Paclitaxel—kidney cancer	0.000109	0.000996	CcSEcCtD
L-Glutamine—Fatigue—Gemcitabine—kidney cancer	0.000109	0.000995	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Vincristine—kidney cancer	0.000109	0.000995	CcSEcCtD
L-Glutamine—Dizziness—Sorafenib—kidney cancer	0.000108	0.000989	CcSEcCtD
L-Glutamine—Pain—Gemcitabine—kidney cancer	0.000108	0.000987	CcSEcCtD
L-Glutamine—Constipation—Gemcitabine—kidney cancer	0.000108	0.000987	CcSEcCtD
L-Glutamine—Nausea—Erlotinib—kidney cancer	0.000108	0.000987	CcSEcCtD
L-Glutamine—Dry mouth—Paclitaxel—kidney cancer	0.000108	0.000986	CcSEcCtD
L-Glutamine—Mental disorder—Capecitabine—kidney cancer	0.000107	0.000978	CcSEcCtD
L-Glutamine—Asthenia—Dactinomycin—kidney cancer	0.000107	0.000977	CcSEcCtD
L-Glutamine—Malnutrition—Capecitabine—kidney cancer	0.000106	0.000972	CcSEcCtD
L-Glutamine—Dehydration—Doxorubicin—kidney cancer	0.000106	0.000967	CcSEcCtD
L-Glutamine—Oedema—Paclitaxel—kidney cancer	0.000106	0.000966	CcSEcCtD
L-Glutamine—Abdominal pain—Vincristine—kidney cancer	0.000105	0.000962	CcSEcCtD
L-Glutamine—Body temperature increased—Vincristine—kidney cancer	0.000105	0.000962	CcSEcCtD
L-Glutamine—Infection—Paclitaxel—kidney cancer	0.000105	0.00096	CcSEcCtD
L-Glutamine—Flatulence—Capecitabine—kidney cancer	0.000105	0.000958	CcSEcCtD
L-Glutamine—Dizziness—Sunitinib—kidney cancer	0.000104	0.000951	CcSEcCtD
L-Glutamine—Feeling abnormal—Gemcitabine—kidney cancer	0.000104	0.000951	CcSEcCtD
L-Glutamine—Vomiting—Sorafenib—kidney cancer	0.000104	0.000951	CcSEcCtD
L-Glutamine—Rash—Sorafenib—kidney cancer	0.000103	0.000943	CcSEcCtD
L-Glutamine—Dermatitis—Sorafenib—kidney cancer	0.000103	0.000942	CcSEcCtD
L-Glutamine—Back pain—Capecitabine—kidney cancer	0.000103	0.00094	CcSEcCtD
L-Glutamine—Headache—Sorafenib—kidney cancer	0.000102	0.000937	CcSEcCtD
L-Glutamine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000102	0.000934	CcSEcCtD
L-Glutamine—Vomiting—Sunitinib—kidney cancer	0.0001	0.000915	CcSEcCtD
L-Glutamine—Body temperature increased—Gemcitabine—kidney cancer	9.98e-05	0.000912	CcSEcCtD
L-Glutamine—Rash—Sunitinib—kidney cancer	9.92e-05	0.000907	CcSEcCtD
L-Glutamine—Dermatitis—Sunitinib—kidney cancer	9.91e-05	0.000906	CcSEcCtD
L-Glutamine—Abdominal distension—Doxorubicin—kidney cancer	9.9e-05	0.000905	CcSEcCtD
L-Glutamine—Ill-defined disorder—Capecitabine—kidney cancer	9.86e-05	0.000902	CcSEcCtD
L-Glutamine—Headache—Sunitinib—kidney cancer	9.85e-05	0.000901	CcSEcCtD
L-Glutamine—Hypersensitivity—Vincristine—kidney cancer	9.8e-05	0.000896	CcSEcCtD
L-Glutamine—Nausea—Sorafenib—kidney cancer	9.71e-05	0.000888	CcSEcCtD
L-Glutamine—Pancreatitis—Doxorubicin—kidney cancer	9.64e-05	0.000881	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	9.63e-05	0.00088	CcSEcCtD
L-Glutamine—Malaise—Capecitabine—kidney cancer	9.58e-05	0.000876	CcSEcCtD
L-Glutamine—Insomnia—Paclitaxel—kidney cancer	9.56e-05	0.000874	CcSEcCtD
L-Glutamine—Asthenia—Vincristine—kidney cancer	9.55e-05	0.000873	CcSEcCtD
L-Glutamine—Vomiting—Dactinomycin—kidney cancer	9.47e-05	0.000866	CcSEcCtD
L-Glutamine—Rash—Dactinomycin—kidney cancer	9.39e-05	0.000859	CcSEcCtD
L-Glutamine—Nausea—Sunitinib—kidney cancer	9.34e-05	0.000854	CcSEcCtD
L-Glutamine—Fatigue—Paclitaxel—kidney cancer	9.11e-05	0.000833	CcSEcCtD
L-Glutamine—Asthenia—Gemcitabine—kidney cancer	9.06e-05	0.000828	CcSEcCtD
L-Glutamine—Chest pain—Capecitabine—kidney cancer	9.05e-05	0.000827	CcSEcCtD
L-Glutamine—Arthralgia—Capecitabine—kidney cancer	9.05e-05	0.000827	CcSEcCtD
L-Glutamine—Myalgia—Capecitabine—kidney cancer	9.05e-05	0.000827	CcSEcCtD
L-Glutamine—Constipation—Paclitaxel—kidney cancer	9.04e-05	0.000826	CcSEcCtD
L-Glutamine—Pain—Paclitaxel—kidney cancer	9.04e-05	0.000826	CcSEcCtD
L-Glutamine—Discomfort—Capecitabine—kidney cancer	8.94e-05	0.000817	CcSEcCtD
L-Glutamine—Pruritus—Gemcitabine—kidney cancer	8.93e-05	0.000817	CcSEcCtD
L-Glutamine—Dry mouth—Capecitabine—kidney cancer	8.85e-05	0.000809	CcSEcCtD
L-Glutamine—Nausea—Dactinomycin—kidney cancer	8.84e-05	0.000809	CcSEcCtD
L-Glutamine—Dizziness—Vincristine—kidney cancer	8.8e-05	0.000805	CcSEcCtD
L-Glutamine—Feeling abnormal—Paclitaxel—kidney cancer	8.71e-05	0.000796	CcSEcCtD
L-Glutamine—Oedema—Capecitabine—kidney cancer	8.67e-05	0.000793	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Paclitaxel—kidney cancer	8.64e-05	0.00079	CcSEcCtD
L-Glutamine—Infection—Capecitabine—kidney cancer	8.61e-05	0.000788	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Doxorubicin—kidney cancer	8.59e-05	0.000786	CcSEcCtD
L-Glutamine—Vomiting—Vincristine—kidney cancer	8.46e-05	0.000774	CcSEcCtD
L-Glutamine—Rash—Vincristine—kidney cancer	8.39e-05	0.000767	CcSEcCtD
L-Glutamine—Hyperhidrosis—Capecitabine—kidney cancer	8.38e-05	0.000767	CcSEcCtD
L-Glutamine—Dermatitis—Vincristine—kidney cancer	8.38e-05	0.000766	CcSEcCtD
L-Glutamine—Abdominal pain—Paclitaxel—kidney cancer	8.35e-05	0.000764	CcSEcCtD
L-Glutamine—Body temperature increased—Paclitaxel—kidney cancer	8.35e-05	0.000764	CcSEcCtD
L-Glutamine—Headache—Vincristine—kidney cancer	8.33e-05	0.000762	CcSEcCtD
L-Glutamine—Vomiting—Gemcitabine—kidney cancer	8.02e-05	0.000734	CcSEcCtD
L-Glutamine—Rash—Gemcitabine—kidney cancer	7.96e-05	0.000728	CcSEcCtD
L-Glutamine—Dermatitis—Gemcitabine—kidney cancer	7.95e-05	0.000727	CcSEcCtD
L-Glutamine—Headache—Gemcitabine—kidney cancer	7.91e-05	0.000723	CcSEcCtD
L-Glutamine—Nausea—Vincristine—kidney cancer	7.9e-05	0.000723	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.9e-05	0.000723	CcSEcCtD
L-Glutamine—Rhinitis—Doxorubicin—kidney cancer	7.89e-05	0.000721	CcSEcCtD
L-Glutamine—Insomnia—Capecitabine—kidney cancer	7.84e-05	0.000717	CcSEcCtD
L-Glutamine—Pharyngitis—Doxorubicin—kidney cancer	7.81e-05	0.000714	CcSEcCtD
L-Glutamine—Hypersensitivity—Paclitaxel—kidney cancer	7.79e-05	0.000712	CcSEcCtD
L-Glutamine—Urinary tract disorder—Doxorubicin—kidney cancer	7.77e-05	0.000711	CcSEcCtD
L-Glutamine—Urethral disorder—Doxorubicin—kidney cancer	7.71e-05	0.000705	CcSEcCtD
L-Glutamine—Asthenia—Paclitaxel—kidney cancer	7.58e-05	0.000693	CcSEcCtD
L-Glutamine—Nausea—Gemcitabine—kidney cancer	7.5e-05	0.000686	CcSEcCtD
L-Glutamine—Fatigue—Capecitabine—kidney cancer	7.48e-05	0.000684	CcSEcCtD
L-Glutamine—Pruritus—Paclitaxel—kidney cancer	7.48e-05	0.000684	CcSEcCtD
L-Glutamine—Pain—Capecitabine—kidney cancer	7.42e-05	0.000678	CcSEcCtD
L-Glutamine—Constipation—Capecitabine—kidney cancer	7.42e-05	0.000678	CcSEcCtD
L-Glutamine—Feeling abnormal—Capecitabine—kidney cancer	7.15e-05	0.000654	CcSEcCtD
L-Glutamine—Angiopathy—Doxorubicin—kidney cancer	7.14e-05	0.000653	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Capecitabine—kidney cancer	7.09e-05	0.000649	CcSEcCtD
L-Glutamine—Chills—Doxorubicin—kidney cancer	7.06e-05	0.000646	CcSEcCtD
L-Glutamine—Dizziness—Paclitaxel—kidney cancer	6.99e-05	0.000639	CcSEcCtD
L-Glutamine—Mental disorder—Doxorubicin—kidney cancer	6.89e-05	0.00063	CcSEcCtD
L-Glutamine—Body temperature increased—Capecitabine—kidney cancer	6.86e-05	0.000627	CcSEcCtD
L-Glutamine—Abdominal pain—Capecitabine—kidney cancer	6.86e-05	0.000627	CcSEcCtD
L-Glutamine—Malnutrition—Doxorubicin—kidney cancer	6.85e-05	0.000626	CcSEcCtD
L-Glutamine—Flatulence—Doxorubicin—kidney cancer	6.75e-05	0.000617	CcSEcCtD
L-Glutamine—Vomiting—Paclitaxel—kidney cancer	6.72e-05	0.000614	CcSEcCtD
L-Glutamine—Rash—Paclitaxel—kidney cancer	6.66e-05	0.000609	CcSEcCtD
L-Glutamine—Dermatitis—Paclitaxel—kidney cancer	6.66e-05	0.000609	CcSEcCtD
L-Glutamine—Back pain—Doxorubicin—kidney cancer	6.63e-05	0.000606	CcSEcCtD
L-Glutamine—Headache—Paclitaxel—kidney cancer	6.62e-05	0.000605	CcSEcCtD
L-Glutamine—Hypersensitivity—Capecitabine—kidney cancer	6.39e-05	0.000584	CcSEcCtD
L-Glutamine—Ill-defined disorder—Doxorubicin—kidney cancer	6.35e-05	0.000581	CcSEcCtD
L-Glutamine—Nausea—Paclitaxel—kidney cancer	6.28e-05	0.000574	CcSEcCtD
L-Glutamine—Asthenia—Capecitabine—kidney cancer	6.22e-05	0.000569	CcSEcCtD
L-Glutamine—Malaise—Doxorubicin—kidney cancer	6.18e-05	0.000565	CcSEcCtD
L-Glutamine—Pruritus—Capecitabine—kidney cancer	6.14e-05	0.000561	CcSEcCtD
L-Glutamine—Arthralgia—Doxorubicin—kidney cancer	5.83e-05	0.000533	CcSEcCtD
L-Glutamine—Myalgia—Doxorubicin—kidney cancer	5.83e-05	0.000533	CcSEcCtD
L-Glutamine—Chest pain—Doxorubicin—kidney cancer	5.83e-05	0.000533	CcSEcCtD
L-Glutamine—Discomfort—Doxorubicin—kidney cancer	5.76e-05	0.000527	CcSEcCtD
L-Glutamine—Dizziness—Capecitabine—kidney cancer	5.73e-05	0.000524	CcSEcCtD
L-Glutamine—Dry mouth—Doxorubicin—kidney cancer	5.7e-05	0.000522	CcSEcCtD
L-Glutamine—Oedema—Doxorubicin—kidney cancer	5.59e-05	0.000511	CcSEcCtD
L-Glutamine—Infection—Doxorubicin—kidney cancer	5.55e-05	0.000508	CcSEcCtD
L-Glutamine—Vomiting—Capecitabine—kidney cancer	5.51e-05	0.000504	CcSEcCtD
L-Glutamine—Rash—Capecitabine—kidney cancer	5.47e-05	0.0005	CcSEcCtD
L-Glutamine—Dermatitis—Capecitabine—kidney cancer	5.46e-05	0.0005	CcSEcCtD
L-Glutamine—Headache—Capecitabine—kidney cancer	5.43e-05	0.000497	CcSEcCtD
L-Glutamine—Hyperhidrosis—Doxorubicin—kidney cancer	5.4e-05	0.000494	CcSEcCtD
L-Glutamine—Nausea—Capecitabine—kidney cancer	5.15e-05	0.000471	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.09e-05	0.000466	CcSEcCtD
L-Glutamine—Insomnia—Doxorubicin—kidney cancer	5.06e-05	0.000462	CcSEcCtD
L-Glutamine—Fatigue—Doxorubicin—kidney cancer	4.82e-05	0.000441	CcSEcCtD
L-Glutamine—Pain—Doxorubicin—kidney cancer	4.78e-05	0.000437	CcSEcCtD
L-Glutamine—Constipation—Doxorubicin—kidney cancer	4.78e-05	0.000437	CcSEcCtD
L-Glutamine—Feeling abnormal—Doxorubicin—kidney cancer	4.61e-05	0.000421	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Doxorubicin—kidney cancer	4.57e-05	0.000418	CcSEcCtD
L-Glutamine—Abdominal pain—Doxorubicin—kidney cancer	4.42e-05	0.000404	CcSEcCtD
L-Glutamine—Body temperature increased—Doxorubicin—kidney cancer	4.42e-05	0.000404	CcSEcCtD
L-Glutamine—Hypersensitivity—Doxorubicin—kidney cancer	4.12e-05	0.000377	CcSEcCtD
L-Glutamine—Asthenia—Doxorubicin—kidney cancer	4.01e-05	0.000367	CcSEcCtD
L-Glutamine—Pruritus—Doxorubicin—kidney cancer	3.95e-05	0.000362	CcSEcCtD
L-Glutamine—GLUL—Neuronal System—BRAF—kidney cancer	3.74e-05	0.000358	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—MAPK1—kidney cancer	3.73e-05	0.000357	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—MAPK1—kidney cancer	3.73e-05	0.000357	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IFNA2—kidney cancer	3.71e-05	0.000355	CbGpPWpGaD
L-Glutamine—Dizziness—Doxorubicin—kidney cancer	3.7e-05	0.000338	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	3.7e-05	0.000353	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.69e-05	0.000353	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ST3GAL2—kidney cancer	3.69e-05	0.000353	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GSTT1—kidney cancer	3.69e-05	0.000353	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GSTT1—kidney cancer	3.69e-05	0.000353	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ACHE—kidney cancer	3.69e-05	0.000353	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ACHE—kidney cancer	3.69e-05	0.000353	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ST3GAL2—kidney cancer	3.69e-05	0.000353	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ACHE—kidney cancer	3.69e-05	0.000353	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GSTT1—kidney cancer	3.69e-05	0.000353	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—BCHE—kidney cancer	3.68e-05	0.000352	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—SLC2A1—kidney cancer	3.66e-05	0.00035	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—JUNB—kidney cancer	3.63e-05	0.000347	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—SLC5A5—kidney cancer	3.63e-05	0.000347	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ALDH1A1—kidney cancer	3.6e-05	0.000345	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ALDH1A1—kidney cancer	3.6e-05	0.000345	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—GSTP1—kidney cancer	3.59e-05	0.000343	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—BCHE—kidney cancer	3.58e-05	0.000342	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.56e-05	0.000341	CbGpPWpGaD
L-Glutamine—Vomiting—Doxorubicin—kidney cancer	3.55e-05	0.000325	CcSEcCtD
L-Glutamine—Rash—Doxorubicin—kidney cancer	3.52e-05	0.000322	CcSEcCtD
L-Glutamine—Dermatitis—Doxorubicin—kidney cancer	3.52e-05	0.000322	CcSEcCtD
L-Glutamine—CAD—Metabolism—CRABP1—kidney cancer	3.51e-05	0.000335	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—SLC2A1—kidney cancer	3.51e-05	0.000335	CbGpPWpGaD
L-Glutamine—Headache—Doxorubicin—kidney cancer	3.5e-05	0.00032	CcSEcCtD
L-Glutamine—GLS—Metabolism—SCARB1—kidney cancer	3.49e-05	0.000334	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—SCARB1—kidney cancer	3.49e-05	0.000334	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—SCARB1—kidney cancer	3.49e-05	0.000334	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS1—kidney cancer	3.46e-05	0.000331	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS1—kidney cancer	3.46e-05	0.000331	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS1—kidney cancer	3.46e-05	0.000331	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PGK1—kidney cancer	3.46e-05	0.000331	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—SLC5A3—kidney cancer	3.46e-05	0.000331	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PGK1—kidney cancer	3.46e-05	0.000331	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—SLC5A3—kidney cancer	3.46e-05	0.000331	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—POMC—kidney cancer	3.43e-05	0.000328	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—ABCB1—kidney cancer	3.4e-05	0.000325	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PSMD7—kidney cancer	3.39e-05	0.000324	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PSMD7—kidney cancer	3.39e-05	0.000324	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PSMD7—kidney cancer	3.39e-05	0.000324	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—LDHB—kidney cancer	3.39e-05	0.000324	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—LDHB—kidney cancer	3.39e-05	0.000324	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN2B—kidney cancer	3.38e-05	0.000324	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IGF2—kidney cancer	3.34e-05	0.000319	CbGpPWpGaD
L-Glutamine—Nausea—Doxorubicin—kidney cancer	3.32e-05	0.000304	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—GSTM1—kidney cancer	3.3e-05	0.000315	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ITPR2—kidney cancer	3.26e-05	0.000312	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—BCHE—kidney cancer	3.21e-05	0.000307	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—BCHE—kidney cancer	3.21e-05	0.000307	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—BCHE—kidney cancer	3.21e-05	0.000307	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CRABP1—kidney cancer	3.21e-05	0.000307	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—RAF1—kidney cancer	3.2e-05	0.000306	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—GSTP1—kidney cancer	3.2e-05	0.000306	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—GSTP1—kidney cancer	3.2e-05	0.000306	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—SLC5A5—kidney cancer	3.17e-05	0.000304	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—SLC5A5—kidney cancer	3.17e-05	0.000304	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—SLC5A5—kidney cancer	3.17e-05	0.000304	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—CYP1A1—kidney cancer	3.13e-05	0.000299	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—RAF1—kidney cancer	3.12e-05	0.000299	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—SLC2A1—kidney cancer	3.06e-05	0.000293	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—SLC2A1—kidney cancer	3.06e-05	0.000293	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—SLC2A1—kidney cancer	3.06e-05	0.000293	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—ABCB1—kidney cancer	3.03e-05	0.000289	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ABCB1—kidney cancer	3.03e-05	0.000289	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ITPR2—kidney cancer	2.98e-05	0.000285	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTT1—kidney cancer	2.97e-05	0.000284	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ACHE—kidney cancer	2.97e-05	0.000284	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN2B—kidney cancer	2.96e-05	0.000283	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—GSTM1—kidney cancer	2.94e-05	0.000281	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CA9—kidney cancer	2.94e-05	0.000281	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CA9—kidney cancer	2.94e-05	0.000281	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—GSTM1—kidney cancer	2.94e-05	0.000281	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—GSTP1—kidney cancer	2.92e-05	0.00028	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—IL2—kidney cancer	2.87e-05	0.000274	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—SCARB1—kidney cancer	2.81e-05	0.000269	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.81e-05	0.000269	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.79e-05	0.000267	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS1—kidney cancer	2.79e-05	0.000266	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CYP1A1—kidney cancer	2.79e-05	0.000266	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CYP1A1—kidney cancer	2.79e-05	0.000266	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—IGF2—kidney cancer	2.77e-05	0.000265	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—ABCB1—kidney cancer	2.77e-05	0.000265	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PSMD7—kidney cancer	2.73e-05	0.000261	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTT1—kidney cancer	2.72e-05	0.00026	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ACHE—kidney cancer	2.72e-05	0.00026	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HIF1A—kidney cancer	2.7e-05	0.000259	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—TSC2—kidney cancer	2.7e-05	0.000258	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—GSTM1—kidney cancer	2.69e-05	0.000257	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—BCHE—kidney cancer	2.59e-05	0.000248	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—SCARB1—kidney cancer	2.57e-05	0.000246	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—SLC5A5—kidney cancer	2.56e-05	0.000245	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GSTP1—kidney cancer	2.56e-05	0.000244	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GSTP1—kidney cancer	2.56e-05	0.000244	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GSTP1—kidney cancer	2.56e-05	0.000244	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS1—kidney cancer	2.55e-05	0.000244	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—CYP1A1—kidney cancer	2.55e-05	0.000244	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—RAF1—kidney cancer	2.53e-05	0.000242	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PSMD7—kidney cancer	2.5e-05	0.000239	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CRABP1—kidney cancer	2.5e-05	0.000239	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CRABP1—kidney cancer	2.5e-05	0.000239	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—SLC2A1—kidney cancer	2.47e-05	0.000236	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—CTNNB1—kidney cancer	2.45e-05	0.000234	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—VEGFA—kidney cancer	2.44e-05	0.000233	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ABCB1—kidney cancer	2.42e-05	0.000231	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ABCB1—kidney cancer	2.42e-05	0.000231	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ABCB1—kidney cancer	2.42e-05	0.000231	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KIT—kidney cancer	2.38e-05	0.000228	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—APC—kidney cancer	2.38e-05	0.000228	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—BCHE—kidney cancer	2.37e-05	0.000227	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HIF1A—kidney cancer	2.36e-05	0.000226	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TSC2—kidney cancer	2.36e-05	0.000226	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GSTM1—kidney cancer	2.35e-05	0.000225	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GSTM1—kidney cancer	2.35e-05	0.000225	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GSTM1—kidney cancer	2.35e-05	0.000225	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—SLC5A5—kidney cancer	2.34e-05	0.000224	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—POMC—kidney cancer	2.33e-05	0.000223	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ITPR2—kidney cancer	2.32e-05	0.000222	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ITPR2—kidney cancer	2.32e-05	0.000222	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—MAPK3—kidney cancer	2.31e-05	0.000221	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—SLC2A1—kidney cancer	2.26e-05	0.000216	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—BRAF—kidney cancer	2.24e-05	0.000214	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CYP1A1—kidney cancer	2.23e-05	0.000213	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CYP1A1—kidney cancer	2.23e-05	0.000213	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CYP1A1—kidney cancer	2.23e-05	0.000213	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—MAPK1—kidney cancer	2.2e-05	0.00021	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—RAF1—kidney cancer	2.15e-05	0.000206	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—MAPK1—kidney cancer	2.14e-05	0.000205	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.14e-05	0.000205	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ACHE—kidney cancer	2.12e-05	0.000203	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ACHE—kidney cancer	2.12e-05	0.000203	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTT1—kidney cancer	2.12e-05	0.000203	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTT1—kidney cancer	2.12e-05	0.000203	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KIT—kidney cancer	2.08e-05	0.000199	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—APC—kidney cancer	2.08e-05	0.000199	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—POMC—kidney cancer	2.08e-05	0.000199	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—POMC—kidney cancer	2.08e-05	0.000199	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—KRAS—kidney cancer	2.07e-05	0.000198	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.07e-05	0.000198	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTP1—kidney cancer	2.06e-05	0.000197	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—SCARB1—kidney cancer	2e-05	0.000192	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—SCARB1—kidney cancer	2e-05	0.000192	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS1—kidney cancer	1.98e-05	0.00019	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS1—kidney cancer	1.98e-05	0.00019	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—BRAF—kidney cancer	1.96e-05	0.000187	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ABCB1—kidney cancer	1.95e-05	0.000187	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PSMD7—kidney cancer	1.95e-05	0.000186	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PSMD7—kidney cancer	1.95e-05	0.000186	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PIK3CA—kidney cancer	1.9e-05	0.000182	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—POMC—kidney cancer	1.9e-05	0.000182	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTM1—kidney cancer	1.89e-05	0.000181	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTP1—kidney cancer	1.88e-05	0.00018	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—RAF1—kidney cancer	1.87e-05	0.000179	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTGS2—kidney cancer	1.86e-05	0.000178	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—POMC—kidney cancer	1.85e-05	0.000177	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—ERBB2—kidney cancer	1.85e-05	0.000177	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—BCHE—kidney cancer	1.85e-05	0.000176	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—BCHE—kidney cancer	1.85e-05	0.000176	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—kidney cancer	1.84e-05	0.000176	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—RAF1—kidney cancer	1.84e-05	0.000176	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MTOR—kidney cancer	1.83e-05	0.000175	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—SLC5A5—kidney cancer	1.82e-05	0.000174	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—SLC5A5—kidney cancer	1.82e-05	0.000174	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CD4—kidney cancer	1.82e-05	0.000174	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTGS2—kidney cancer	1.81e-05	0.000173	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CYP1A1—kidney cancer	1.79e-05	0.000172	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ABCB1—kidney cancer	1.78e-05	0.000171	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—SLC2A1—kidney cancer	1.76e-05	0.000168	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—SLC2A1—kidney cancer	1.76e-05	0.000168	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTM1—kidney cancer	1.73e-05	0.000166	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN1B—kidney cancer	1.71e-05	0.000164	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—POMC—kidney cancer	1.66e-05	0.000159	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—POMC—kidney cancer	1.66e-05	0.000159	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—POMC—kidney cancer	1.66e-05	0.000159	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTGS2—kidney cancer	1.66e-05	0.000158	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTGS2—kidney cancer	1.66e-05	0.000158	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IL2—kidney cancer	1.65e-05	0.000158	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CYP1A1—kidney cancer	1.64e-05	0.000157	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—RAF1—kidney cancer	1.63e-05	0.000156	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.63e-05	0.000156	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTEN—kidney cancer	1.62e-05	0.000155	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CTNNB1—kidney cancer	1.62e-05	0.000155	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—ERBB2—kidney cancer	1.62e-05	0.000155	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MTOR—kidney cancer	1.6e-05	0.000153	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CD4—kidney cancer	1.59e-05	0.000152	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—RAF1—kidney cancer	1.59e-05	0.000152	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MAPK3—kidney cancer	1.59e-05	0.000152	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTGS2—kidney cancer	1.58e-05	0.000151	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTEN—kidney cancer	1.58e-05	0.000151	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MYC—kidney cancer	1.54e-05	0.000148	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTGS2—kidney cancer	1.52e-05	0.000145	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN1B—kidney cancer	1.5e-05	0.000143	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTP1—kidney cancer	1.47e-05	0.00014	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTP1—kidney cancer	1.47e-05	0.00014	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTEN—kidney cancer	1.44e-05	0.000138	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTEN—kidney cancer	1.44e-05	0.000138	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CTNNB1—kidney cancer	1.41e-05	0.000135	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VEGFA—kidney cancer	1.4e-05	0.000134	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ABCB1—kidney cancer	1.39e-05	0.000133	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ABCB1—kidney cancer	1.39e-05	0.000133	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTEN—kidney cancer	1.38e-05	0.000132	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTM1—kidney cancer	1.35e-05	0.000129	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTM1—kidney cancer	1.35e-05	0.000129	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MAPK3—kidney cancer	1.35e-05	0.000129	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—POMC—kidney cancer	1.34e-05	0.000128	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—MAPK3—kidney cancer	1.33e-05	0.000127	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS2—kidney cancer	1.32e-05	0.000127	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS2—kidney cancer	1.32e-05	0.000127	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS2—kidney cancer	1.32e-05	0.000127	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTEN—kidney cancer	1.32e-05	0.000126	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CTNNB1—kidney cancer	1.32e-05	0.000126	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MYC—kidney cancer	1.31e-05	0.000125	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MAPK1—kidney cancer	1.28e-05	0.000123	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP1A1—kidney cancer	1.28e-05	0.000122	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP1A1—kidney cancer	1.28e-05	0.000122	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—MAPK1—kidney cancer	1.26e-05	0.000121	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—POMC—kidney cancer	1.22e-05	0.000117	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KRAS—kidney cancer	1.21e-05	0.000116	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—KRAS—kidney cancer	1.19e-05	0.000114	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MAPK3—kidney cancer	1.18e-05	0.000113	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTEN—kidney cancer	1.15e-05	0.00011	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTEN—kidney cancer	1.15e-05	0.00011	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTEN—kidney cancer	1.15e-05	0.00011	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MYC—kidney cancer	1.15e-05	0.00011	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CA—kidney cancer	1.14e-05	0.000109	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MAPK1—kidney cancer	1.12e-05	0.000107	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CA—kidney cancer	1.11e-05	0.000106	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CA—kidney cancer	1.09e-05	0.000105	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS2—kidney cancer	1.07e-05	0.000102	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KRAS—kidney cancer	1.06e-05	0.000101	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—kidney cancer	1.06e-05	0.000101	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CA—kidney cancer	1.02e-05	9.75e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CA—kidney cancer	1.02e-05	9.75e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS2—kidney cancer	9.76e-06	9.34e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CA—kidney cancer	9.73e-06	9.31e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—POMC—kidney cancer	9.54e-06	9.12e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—POMC—kidney cancer	9.54e-06	9.12e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CA—kidney cancer	9.32e-06	8.92e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTEN—kidney cancer	9.31e-06	8.9e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—RAF1—kidney cancer	9.23e-06	8.83e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTEN—kidney cancer	8.51e-06	8.14e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CA—kidney cancer	8.15e-06	7.79e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CA—kidney cancer	8.15e-06	7.79e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CA—kidney cancer	8.15e-06	7.79e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS2—kidney cancer	7.61e-06	7.27e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS2—kidney cancer	7.61e-06	7.27e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTEN—kidney cancer	6.63e-06	6.34e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTEN—kidney cancer	6.63e-06	6.34e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CA—kidney cancer	6.57e-06	6.28e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CA—kidney cancer	6.01e-06	5.75e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CA—kidney cancer	4.68e-06	4.48e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CA—kidney cancer	4.68e-06	4.48e-05	CbGpPWpGaD
